Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL

Published:2021-12-06 Issue:23 Volume:5 Page:5112-5115
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Miller Jemima H.¹,Gilbertson Michael¹²,MacManus Michael P.³⁴^ORCID,Wirth Andrew³⁴,Opat Stephen S.¹²^ORCID,Gregory Gareth P.¹²^ORCID

Affiliation:

1. Monash Haematology, Monash Health, Melbourne, VIC, Australia;

2. School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia;

3. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and

4. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/5/23/5112/1849187/advancesadv2021005061.pdf

Reference7 articles.

1. Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP;Freeman;Blood.,2021

2. PET response-guided radiotherapy for advanced DLBCL?;Wirth;Blood.,2021

3. Consolidative radiotherapy to residual masses after chemotherapy is associated with improved outcome in diffuse large B-cell lymphoma. A retrospective, population-based study;Fluge;Clin Lymphoma Myeloma Leuk.,2018

4. Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin’s lymphoma;Moser;Int J Radiat Oncol Biol Phys.,2006

5. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group;Illidge;Int J Radiat Oncol Biol Phys.,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy;Expert Review of Hematology;2022-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3